{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:34Z","timestamp":1791856114028,"version":"4.3.4"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The European Journal of Contraception & Reproductive Health Care"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/13625187.2024.2398433","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:21:44Z","timestamp":1726478504000},"page":"3-12","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2\u2009mg\/ethinylestradiol 0.02\u2009mg versus an immediate-release formulation of drospirenone 3\u2009mg\/ethinylestradiol 0.02\u2009mg"],"prefix":"10.1080","volume":"30","author":[{"given":"Kristina","family":"Biskupska-Bodova","sequence":"first","affiliation":[{"name":"Aetas, Private Gynecology Practice","place":["Turcianske Teplice, Slovakia"]},{"name":"Department of Gynecology and Obstetrics, University Hospital","place":["Martin, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"S\u00f3jka-Kupny","sequence":"additional","affiliation":[{"name":"Medicor Medical Center","place":["Bieru\u0144, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Nyir\u00e1dy","sequence":"additional","affiliation":[{"name":"Gynecology Private, Hiroslezer Center","place":["Kecskemet, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Burke","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicyoy","family":"Angulo","sequence":"additional","affiliation":[{"name":"Chemo Group, Exeltis Pharma","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2847","authenticated-orcid":false,"given":"Pedro Antonio","family":"Regidor","sequence":"additional","affiliation":[{"name":"Exeltis Healthcare","place":["Ismaning, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614548857"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6423"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.12.018"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2023.110310"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115799"},{"issue":"1","key":"e_1_3_5_7_1","first-page":"91","article-title":"Venous thromboembolism in relation to oral contraceptive use","volume":"69","author":"Helmrich SP","year":"1987","unstructured":"Helmrich SP, Rosenberg L, Kaufman DW, et\u00a0al. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol. 1987;69(1):91\u201395.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.1.48"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6519.526"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2017.1413179"},{"key":"e_1_3_5_11_1","first-page":"53","article-title":"Clincal findings with the dienogest-contraing oral contraceptive Valette","volume":"35","author":"Moore C","year":"1999","unstructured":"Moore C, Feichtinger W, Klinger G, et\u00a0al. Clincal findings with the dienogest-contraing oral contraceptive Valette. Drugs of Today. 1999;35:53\u201368.","journal-title":"Drugs of Today"},{"key":"e_1_3_5_12_1","first-page":"1","article-title":"Gynaeclogical uses of dienogest alone and in combination with oestrogens","volume":"5","author":"Bartsch V.","year":"2015","unstructured":"Bartsch V. Gynaeclogical uses of dienogest alone and in combination with oestrogens. J Med Drug Rev. 2015;5:1\u201331.","journal-title":"J Med Drug Rev"},{"key":"e_1_3_5_13_1","first-page":"3","article-title":"The preclinical and clinical profile of dienogest A short overview","volume":"35","author":"Oettel M","year":"1999","unstructured":"Oettel M, Graeser T, Hoffmann H, et\u00a0al. The preclinical and clinical profile of dienogest A short overview. Drugs of Today. 1999;35(Suppl C):3\u201312.","journal-title":"Drugs of Today"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.08.012"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13688"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231856"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.1963432"},{"key":"e_1_3_5_18_1","unstructured":"Valette. Summary of product characteristics. Bayer AG. 2024. Available from: https:\/\/resources.bayer.com.au\/resources\/uploads\/PI\/file9439.pdf"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2011-100213"},{"key":"e_1_3_5_20_1","unstructured":"Kelzy. dienogest\/ethinyl estradiol 2\u2009mg\/0.02\u2009mg prolonged-release tablets. Summary of Product Characteristics. 2024. Available from: https:\/\/docetp.mpa.se\/LMF\/Dienogest_Ethinylestradiol%20Exeltis%20prolonged-release%20tablets%20ENG%20SmPC_09001bee83c7d1de.pdf"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-5122(96)82003-2"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2004.05.013"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/OAJC.S83080"},{"issue":"5","key":"e_1_3_5_24_1","first-page":"355","article-title":"Efficacy and safety of a combined oral contraceptive containing drospirenone 3\u2009mg and ethinylestradiol 20 microg in a 24\u2009+\u20094-day regimen in China","volume":"49","author":"Caiyan W","year":"2014","unstructured":"Caiyan W, Wen D, Qinping L, et\u00a0al. Efficacy and safety of a combined oral contraceptive containing drospirenone 3\u2009mg and ethinylestradiol 20 microg in a 24\u2009+\u20094-day regimen in China. Zhonghua Fu Chan Ke Za Zhi. 2014;49(5):355\u2013359.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2009.01.016"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2010.12.037"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.07.004"},{"key":"e_1_3_5_28_1","unstructured":"NuvaRing Summary of Product Characteristics. Organon Pharma. 2011. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/6449\/smpc"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181842071"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(96)00994-2"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.01.045"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2002"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2016.1161743"}],"container-title":["The European Journal of Contraception & Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13625187.2024.2398433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:05:10Z","timestamp":1739289910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13625187.2024.2398433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/13625187.2024.2398433"],"URL":"https:\/\/doi.org\/10.1080\/13625187.2024.2398433","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"value":"1362-5187","type":"print"},{"value":"1473-0782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}